Corvus Pharmaceuticals Inc buy Cantor Fitzgerald
Start price
16:15
/
50%
€7.33
Target price
11.12.26
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 11.12.26. The prediction end date can be changed by Cantor_Fitzgerald at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Corvus Pharmaceuticals Inc | - |
| iShares Core DAX® | 1.803% |
| iShares Nasdaq 100 | 0.429% |
| iShares Nikkei 225® | 0.708% |
| iShares S&P 500 | 0.288% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for CRVS provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.67
01.04.24
01.04.24
-
01.04.25
01.04.25
71.74%
02.04.25
02.04.25
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.51
07.09.23
07.09.23
€3.74
07.09.24
07.09.24
146.36%
08.09.24
08.09.24

